PHOTO-CYCLE | Photocatalysis in Drug Discovery - Asymmetric Preparation of Bioactive Chiral Lactones and Cyclohexanols

Summary
We are in a changing era for drug discovery: the growing perception is that basic chemical research will play a greater role in pharmaceutical development. One current challenge is to develop a new kind of chemistry that yields a screening collection of optimal chiral molecules that increase the probability of success in identifying drug-candidate structures. PHOTO-CYCLE seeks to provide some solutions by developing effective technology to rapidly generate, in one single step, architecturally complex chiral natural-like compounds. Specifically, we will use photochemical organocatalytic cascade processes to synthesise polycyclic lactones and polyfunctionalized cyclohexanols, which are common motifs in biologically active molecules. We will combine asymmetric organocatalysis and photochemistry, two powerful strategies of modern chemical research. They have extraordinary potential for the sustainable preparation of novel organic molecules, which are needed to drive innovation in the pharmaceutical industry.
PHOTO-CYCLE aims to combine the fellow’s experience in allene chemistry and organocatalysis and the host’s experience in photo-triggered asymmetric processes to develop otherwise unachievable catalytic asymmetric cascade reactions. Specifically, we will focus on the rich reactivity of excited chiral iminium ions to activate readily available allenes and trigger cascade processes. The resulting strategies will be used as an ideal platform for assembling libraries comprising chiral polycyclic lactones and cyclohexanols, which, along with biological screening carried out in collaboration with Lundbeck A/S, will increase the probability of success in identifying drug-candidate structures.
The multi-cultural and intersectorial nature of this project will greatly contribute to broaden the fellow’s competencies and will place him in a competitive position for the next career move.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/894795
Start date: 01-03-2020
End date: 28-02-2022
Total budget - Public funding: 160 932,48 Euro - 160 932,00 Euro
Cordis data

Original description

We are in a changing era for drug discovery: the growing perception is that basic chemical research will play a greater role in pharmaceutical development. One current challenge is to develop a new kind of chemistry that yields a screening collection of optimal chiral molecules that increase the probability of success in identifying drug-candidate structures. PHOTO-CYCLE seeks to provide some solutions by developing effective technology to rapidly generate, in one single step, architecturally complex chiral natural-like compounds. Specifically, we will use photochemical organocatalytic cascade processes to synthesise polycyclic lactones and polyfunctionalized cyclohexanols, which are common motifs in biologically active molecules. We will combine asymmetric organocatalysis and photochemistry, two powerful strategies of modern chemical research. They have extraordinary potential for the sustainable preparation of novel organic molecules, which are needed to drive innovation in the pharmaceutical industry.
PHOTO-CYCLE aims to combine the fellow’s experience in allene chemistry and organocatalysis and the host’s experience in photo-triggered asymmetric processes to develop otherwise unachievable catalytic asymmetric cascade reactions. Specifically, we will focus on the rich reactivity of excited chiral iminium ions to activate readily available allenes and trigger cascade processes. The resulting strategies will be used as an ideal platform for assembling libraries comprising chiral polycyclic lactones and cyclohexanols, which, along with biological screening carried out in collaboration with Lundbeck A/S, will increase the probability of success in identifying drug-candidate structures.
The multi-cultural and intersectorial nature of this project will greatly contribute to broaden the fellow’s competencies and will place him in a competitive position for the next career move.

Status

TERMINATED

Call topic

MSCA-IF-2019

Update Date

28-04-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.1. EXCELLENT SCIENCE
H2020-EU.1.3. EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions (MSCA)
H2020-EU.1.3.2. Nurturing excellence by means of cross-border and cross-sector mobility
H2020-MSCA-IF-2019
MSCA-IF-2019